Screener
Beam Therapeutics BEAM Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Beam Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:22 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210338
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Restricted cash | 6,693 | 6,676 |
| Operating lease right-of-use assets | 98,148 | 100,679 |
| Other assets | 7,757 | 634 |
| Total assets | $1,480,798 | $1,481,177 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $12,286 | $10,231 |
| Accrued expenses and other current liabilities | 39,291 | 55,267 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Beam Therapeutics's total assets?
- Beam Therapeutics (BEAM) reported total assets of $1.48B in Q1 2026.
- How has Beam Therapeutics's total assets changed year-over-year?
- Beam Therapeutics's total assets increased by 0.9% year-over-year, from $1.47B to $1.48B.
- What is the long-term trend for Beam Therapeutics's total assets?
- Over 5 years (2020 to 2025), Beam Therapeutics's total assets has grown at a 26.8% compound annual growth rate (CAGR), from $451.68M to $1.48B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Beam Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude